Skip to content
NeuroTechGuide

BrainsWay says US insurance coverage for Deep TMS in OCD passes 118 million people

BrainsWay reports that medical policies covering its Deep TMS treatment for obsessive-compulsive disorder now reach more than 118 million Americans.

In briefNeuromodulationIndustry

BrainsWay announced on October 26 that more than 118 million Americans are now covered by medical policies that pay for its Deep TMS treatment for obsessive-compulsive disorder (OCD). The company did not name the insurers or policies behind the latest increase. It also pointed to recently expanded coverage for its accelerated SWIFT protocol for depression. Deep TMS is cleared by the FDA as an add-on treatment for adults with OCD, and BrainsWay says it was the first company cleared for a noninvasive brain stimulation treatment for the condition.

Insurance coverage is often what decides whether people can get a cleared neuromodulation therapy outside a few specialty clinics. These are the company’s own figures, and being covered by a policy does not mean every plan member will qualify for treatment.

Learn more: Transcranial magnetic stimulation · BrainsWay

Share:XLinkedInBlueskyEmail

More news